EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Potential benefits of therapeutic drug monitoring for beta-lactam antibiotics in augmented renal clearance patients: a case report

Ibrahim El-Haffaf iD, Jean Laverdière, Martin Albert, Amélie Marsot, David Williamson

Canadian Journal of Physiology and Pharmacology · 2024

DOI: 10.1139/cjpp-2023-0109 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Canadian Journal of Physiology and Pharmacology, 2024. Verfasst von Ibrahim El-Haffaf und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, Université de Montréal, Montreal, QC, Canada. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, beta Lactam Antibiotics. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canadian Society of Hospital Pharmacists, Fonds de Recherche du Québec-Santé, Université de Montréal.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Augmented renal clearance (ARC) is commonly described in critically ill patients, making drug pharmacokinetics even harder to predict in this population. This case report displays the value of therapeutic drug monitoring (TDM) of piperacillin/tazobactam (PTZ) in this population. We identified two patients with ARC and intermittent administration of PTZ who took part in a prospective, descriptive study conducted at Hôpital du Sacré-Cœur de Montréal. Both had plasma samples drawn at peak, middle, and end of their dosing intervals of PTZ. Minimal inhibitory concentrations (MICs) of 4 and 8 mg/L were chosen to evaluate therapeutic target attainment at middle and end of dosing interval. The first patient was a 52-year-old male with a renal clearance rate estimated at 147 mL/min who received 3.375 g PTZ every 6 h. The second patient, a 49-year-old male, had an estimated renal clearance rate of 163 mL/min and received the same regimen. Both patients had piperacillin concentrations above the target MICs at middle of the dosing interval, but they failed to reach a trough concentration above 8 mg/L. The present case report showcases two patients with subtherapeutic PTZ concentrations despite strict following of local administration protocols. This suboptimal administration could not only lead to treatment failure, but also to the selection and growth of resistant pathogens. Implementing TDM would offer the possibility to adjust drug regimens in real-time and prevent situations like these from occurring.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial Agentsbeta Lactam AntibioticsMaleHumansMiddle AgedProspective StudiesDrug MonitoringPiperacillinPiperacillin, Tazobactam Drug CombinationMonobactams

Stichwörter der Autor:innen

augmented renal clearancecritically illpiperacillintherapeutic drug monitoring

Substanzen

Anti-Bacterial Agentsbeta Lactam AntibioticsPiperacillinPiperacillin, Tazobactam Drug CombinationMonobactams

Autor:innen und Institutionen

  • Faculty of Pharmacy, Université de Montréal, Montreal, QC, Canada.
  • Laboratoire de Suivi Thérapeutique Pharmacologique et Pharmacocinétique, Faculty of Pharmacy, Université de Montréal, Montreal, QC, Canada.
  • Hôpital du Sacré-Cœur de Montréal, CIUSSS NIM Research Center, Montreal, QC, Canada.
  • Faculty of Medicine, Université de Montréal, Montreal, QC, Canada.
  • Centre de recherche, CHU Sainte-Justine, Montréal, QC, Canada.

ORCID-Profile: Ibrahim El-Haffaf

Förderung

  • Canadian Society of Hospital Pharmacists
  • Fonds de Recherche du Québec-Santé
  • Université de Montréal

Zitieren

APA

El-Haffaf, I., Laverdière, J., Albert, M., Marsot, A., & Williamson, D. (2024). Potential benefits of therapeutic drug monitoring for beta-lactam antibiotics in augmented renal clearance patients: a case report. Canadian Journal of Physiology and Pharmacology. https://doi.org/10.1139/cjpp-2023-0109

Vancouver

El-Haffaf I, Laverdière J, Albert M, Marsot A, Williamson D. Potential benefits of therapeutic drug monitoring for beta-lactam antibiotics in augmented renal clearance patients: a case report. Canadian Journal of Physiology and Pharmacology. 2024. doi:10.1139/cjpp-2023-0109

BibTeX
@article{ElHaffaf2024,
  author = {El-Haffaf, Ibrahim and Laverdière, Jean and Albert, Martin and Marsot, Amélie and Williamson, David},
  title = {Potential benefits of therapeutic drug monitoring for beta-lactam antibiotics in augmented renal clearance patients: a case report},
  journal = {Canadian Journal of Physiology and Pharmacology},
  year = {2024},
  doi = {10.1139/cjpp-2023-0109}
}
Kostenlos starten →